Sentences with phrase «adverse event reporting program»

Cardiologists and Risk Managers will be reporting any emergent situations, health issues or side effects that relate to the malfunction of the component sin the Arstasis One Access System to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.
The ASPCA Animal Product Safety Service supports corporate product stewardship initiatives by providing an extensive animal product safety and adverse event reporting program.

Not exact matches

Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.
American Academy of Veterinary Nutrition http://www.aavn.org/ Academy of Veterinary Nutrition Technicians http://nutritiontechs.org American Society of Clinical Nutrition http://www.nutrition.org/ American Society for Parenteral & Enteral Nutrition https://www.nutritioncare.org/ Amino Acid Laboratory, University of California, Davis http://www.vetmed.ucdavis.edu/vmb/labs/aal/ Association of American Feed Control Officials http://www.aafco.org/ Consumerlab.com (tests dietary supplements for purity, potency, bioavailability, etc) http://www.consumerlab.com/ FDA Center for Food Safety and Applied Nutrition (regulatory and safety issues, adverse event reporting, meetings, industry information) http://www.fda.gov/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/ or http://www.fda.gov/Food/default.htm FDA Center for Veterinary Medicine http://www.fda.gov/AnimalVeterinary/ FDA Recall List http://www.fda.gov/AnimalVeterinary/SafetyHealth/RecallsWithdrawals/default.htm NIH National Center for Complementary and Alternative Medicine http://nccam.nih.gov NIH Office of Dietary Supplements (fact sheets, safety notices, database) http://dietary-supplements.info.nih.gov Nutrient Composition of Whole Vertebrate Prey http://wildpro.twycrosszoo.org/000ADOBES/Bears/D317WholePreyFinal02May29.pdf Nutrition Advisory Group to the American Zoo and Aquarium Association http://nagonline.net/ Pet Food Institute http://www.petfoodinstitute.org/ Pet Food Institute Consumer Information http://www.petfoodinstitute.org/?s=consumer+guide USDA Food and Nutrition Information Center (general supplement and nutrition information, links to a variety of dietary supplement websites) https://www.nal.usda.gov/fnic United State Pharmacopeia Dietary Supplement Verification Program http://www.usp.org/verification-services WSAVA — Global Nutrition Committee — Nutrition Toolkit & Guidelines http://www.wsava.org/guidelines/global-nutrition-guidelines
Her role in pharmacovigilance reporting required her to gather information on products and adverse events from veterinarians across the U.S. Previously, Dr. Miller completed the American Veterinary Medical Association (AVMA) Congressional Fellowship program and later worked in federal government relations for the AVMA.
Such programs would include monitoring reported adverse events under current regulations.
Typical work duties listed on a Drug Safety Specialist resume example are coordinating adverse events programs, following up on case reports, offering information on product safety to healthcare experts, and updating their knowledge of pharmacovigilance.
a b c d e f g h i j k l m n o p q r s t u v w x y z